Evidence map›Paper›PMID 37605057›Full record

ArticleNature metabolism2023

Glutarate regulates T cell metabolism and anti-tumour immunity.

Eleanor Minogue, Pedro P Cunha, Brennan J Wadsworth, Guinevere L Grice, Shiv K Sah-Teli, Rob Hughes, David Bargiela, Alessandro Quaranta, Javier Zurita, Robin Antrobus and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Role of Ferredoxin 1Cancer pathogenesis and therapy · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Metabolic Checkpoints in CD8International journal of biological sciences · 2026
    Review
  13. Article
  14. A Genetically Encoded Biosensor for Characterizing Transport and Metabolism of Glutarate.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Eleanor MinogueDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-4418-445X
Pedro P CunhaDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Brennan J WadsworthDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-9183-227X
Guinevere L GriceCambridge Institute of Therapeutic Immunology & Infectious Disease, Department of Medicine, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Shiv K Sah-TeliBiocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Centre for Cell-Matrix Research, University of Oulu, Oulu, Finland.ORCID http://orcid.org/0000-0001-7285-8522
Rob HughesDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
David BargielaDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Alessandro QuarantaUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3167-3772
Javier ZuritaUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2561-6875
Robin AntrobusCambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Pedro VelicaDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Laura BarbieriDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-9932-2664
Craig E WheelockUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8113-0653
Peppi KoivunenBiocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Centre for Cell-Matrix Research, University of Oulu, Oulu, Finland.
James A NathanCambridge Institute of Therapeutic Immunology & Infectious Disease, Department of Medicine, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-0248-1632
Iosifina P FoskolouDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-1874-6356
Randall S JohnsonDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. randall.johnson@ki.se.ORCID http://orcid.org/0000-0002-4084-6639
University of Cambridge · GBKarolinska Institutet · SEUniversity of Oulu · FIKarolinska University Hospital · SE

Funding

Wellcome Trust 214283/Z/19/ZWellcome Trust 215477/Z/19/Z
6 · The paper itself

Abstract

T cell function and fate can be influenced by several metabolites: in some cases, acting through enzymatic inhibition of α-ketoglutarate-dependent dioxygenases, in others, through post-translational modification of lysines in important targets. We show here that glutarate, a product of amino acid catabolism, has the capacity to do both, and has potent effects on T cell function and differentiation. We found that glutarate exerts those effects both through α-ketoglutarate-dependent dioxygenase inhibition, and through direct regulation of T cell metabolism via glutarylation of the pyruvate dehydrogenase E2 subunit. Administration of diethyl glutarate, a cell-permeable form of glutarate, alters CD8

Indexed as

Biochemical PhenomenaCD8-Positive T-LymphocytesGlutaratesGlutarates

Identifiers

PMID37605057
PMCPMC10590756
OpenAlexW4386033544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.